Search results
Alison Lawton (born May 29, 1970) is a Canadian social venture philanthropist, social advocate, and business investor.
View Alison Lawton’s profile on LinkedIn, a professional community of 1 billion members. Seasoned Biotech Executive with experience as CEO, Chair and independent director of…
- 500+
- Dianthus Therapeutics, Inc.
- 2.2K
Jun 25, 2024 · Alison Lawton is an experienced biopharma executive and a board member of Dianthus Therapeutics, a company developing gene therapy for rare diseases. She has also served as CEO of Kaleido Biosciences and COO of Aura Biosciences, among other roles.
Alison Lawton most recently served as Kaleido’s Chief Executive Officer, President and as a member of the Board of Directors since August 2018, after initially joining the company as President and Chief Operating Officer in December 2017. Ms.
- Chair
- Magenta Therapeutics, Magenta Therapeutics
Alison Lawton is an executive leader with more than 30 years of biopharma experience, having most recently served as president and CEO of Kaleido Biosciences. Previously, she served as chief operating officer (COO) of Aura Biosciences and OvaScience.
Alison Lawton is the founder and president of Mindset Venture Group, a company that invests in early-stage businesses and social ventures. She has a diverse portfolio of investments in technology, consumer, and real estate sectors, and is also involved in global health and social impact initiatives.
People also ask
Who is Alison Lawton?
Who is Alison law solicitors?
Who is Lawton lawyers?
Dec 17, 2020 · Lawton currently serves as independent director for X4 Pharmaceuticals and ProQR Therapeutics and has served on the Boards of Directors of Verastem, CoLucid until its acquisition by Eli Lilly, and Cubist Pharmaceuticals until its acquisition by Merck & Co.
